Skip to main content

DESVENLAFAXINE

Tracking # 20-1055884

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

DESVENLAFAXINE IS AN ANTIDEPRESSANT THAT IS AN FDA-APPROVED DRUG TO TREAT MAJOR DEPRESSIVE DISORDER IN ADULTS. FOR HEALTHY WOMEN WHO HAVE CONTRAINDICATIONS TO ESTROGEN, DESVENLAFAXINE CAN BE USED OFF-LABEL TO TREAT HOT FLASHES DURING MENOPAUSE. ALTHOUGH NOT FDA APPROVED IN ADOLESCENTS, THE TORDIA STUDIES HAVE SHOWN THAT SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS LIKE VENLAFAXINE HAVE EFFICACY IN TREATING MAJOR DEPRESSIVE DISORDER IN TREATMENT-RESISTANT DEPRESSION IN ADOLESCENTS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS OF DESVENLAFAXINE, PERTINENT FOR INTERPROFESSIONAL TEAM MEMBERS DURING DESVENLAFAXINE THERAPY.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I